|
1
|
Baumgart DC and Sandborn WJ: Crohn's
disease. Lancet. 380:1590–1605. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Danese S and Fiocchi C: Ulcerative
colitis. N Engl J Med. 365:1713–1725. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ananthakrishnan AN: Epidemiology and risk
factors for IBD. Nat Rev Gastroenterol Hepatol. 12:205–217. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ng SC, Shi HY, Hamidi N, Underwood FE,
Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JCY, Chan FKL, et
al: Worldwide incidence and prevalence of inflammatory bowel
disease in the 21st century: A systematic review of
population-based studies. Lancet. 390:2769–2778. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Høivik ML, Moum B, Solberg IC, Henriksen
M, Cvancarova M and Bernklev T: IBSEN Group: Work disability in
inflammatory bowel disease patients 10 years after disease onset:
Results from the IBSEN Study. Gut. 62:368–375. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gionchetti P, Dignass A, Danese S, Dias
Magro FJ, Rogler G, Lakatos PL, Adamina M, Ardizzone S, Buskens CJ,
Sebastian S, et al: 3rd European Evidence-based Consensus on the
Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical
management and special situations. J Crohns Colitis. 11:135–149.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kaplan GG and Ng SC: Understanding and
preventing the global increase of inflammatory bowel disease.
Gastroenterology. 152:313–321.e2. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Belkaid Y and Hand TW: Role of the
microbiota in immunity and inflammation. Cell. 157:121–141. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Blander JM, Longman RS, Iliev ID,
Sonnenberg GF and Artis D: Regulation of inflammation by microbiota
interactions with the host. Nat Immunol. 18:851–860. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Caballero S and Pamer EG:
Microbiota-mediated inflammation and antimicrobial defense in the
intestine. Annu Rev Immunol. 33:227–256. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cullen TW, Schofield WB, Barry NA, Putnam
EE, Rundell EA, Trent MS, Degnan PH, Booth CJ, Yu H and Goodman A:
Gut microbiota. Antimicrobial peptide resistance mediates
resilience of prominent gut commensals during inflammation.
Science. 347:170–175. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Miyoshi J and Chang EB: The gut microbiota
and inflammatory bowel diseases. Transl Res. 179:38–48. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Eppinga H, Fuhler GM, Peppelenbosch MP and
Hecht GA: Gut microbiota developments with emphasis on inflammatory
bowel disease: Report from the Gut Microbiota for Health World
Summit 2016. Gastroenterology. 151:e1–e4. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Machiels K, Joossens M, Sabino J, De
Preter V, Arijs I, Eeckhaut V, Ballet V, Claes K, Van Immerseel F,
Verbeke K, et al: A decrease of the butyrate-producing species
Roseburia hominis and Faecalibacterium prausnitzii defines
dysbiosis in patients with ulcerative colitis. Gut. 63:1275–1283.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tilg H and Danese S: Roseburia hominis: A
novel guilty player in ulcerative colitis pathogenesis? Gut.
63:1204–1205. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Neurath MF: Cytokines in inflammatory
bowel disease. Nat Rev Immunol. 14:329–342. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
van der Veeken J, Gonzalez AJ, Cho H,
Arvey A, Hemmers S, Leslie CS and Rudensky AY: Memory of
inflammation in regulatory T cells. Cell. 166:977–990. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Himmel ME, Yao Y, Orban PC, Steiner TS and
Levings MK: Regulatory T-cell therapy for inflammatory bowel
disease: More questions than answers. Immunology. 136:115–122.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Krieglstein CF, Cerwinka WH, Laroux FS,
Grisham MB, Schürmann G, Brüwer M and Granger DN: Role of appendix
and spleen in experimental colitis. J Surg Res. 101:166–175. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Neurath MF, Fuss I, Kelsall BL, Stüber E
and Strober W: Antibodies to interleukin 12 abrogate established
experimental colitis in mice. J Exp Med. 182:1281–1290. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cua DJ and Tato CM: Innate IL-17-producing
cells: The sentinels of the immune system. Nat Rev Immunol.
10:479–489. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rosen MJ, Karns R, Vallance JE, Bezold R,
Waddell A, Collins MH, Haberman Y, Minar P, Baldassano RN, Hyams
JS, et al: Mucosal expression of type 2 and type 17 immune response
genes distinguishes ulcerative colitis from colon-only Crohn's
disease in treatment-naive pediatric patients. Gastroenterology.
152:1345–1357.e7. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Geremia A, Arancibia-Cárcamo CV, Fleming
MP, Rust N, Singh B, Mortensen NJ, Travis SP and Powrie F:
IL-23-responsive innate lymphoid cells are increased in
inflammatory bowel disease. J Exp Med. 208:1127–1133. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vanhove W, Peeters PM, Staelens D,
Schraenen A, Van der Goten J, Cleynen I, De Schepper S, Van Lommel
L, Reynaert NL, Schuit F, et al: Strong upregulation of AIM2 and
IFI16 inflammasomes in the mucosa of patients with active
inflammatory bowel disease. Inflamm Bowel Dis. 21:2673–2682. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Olsen J, Gerds TA, Seidelin JB, Csillag C,
Bjerrum JT, Troelsen JT and Nielsen OH: Diagnosis of ulcerative
colitis before onset of inflammation by multivariate modeling of
genome-wide gene expression data. Inflamm Bowel Dis. 15:1032–1038.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sartor RB and Wu GD: Roles for intestinal
bacteria, viruses, and fungi in pathogenesis of inflammatory bowel
diseases and therapeutic approaches. Gastroenterology.
152:327–339.e4. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tsilingiri K, Barbosa T, Penna G, Caprioli
F, Sonzogni A, Viale G and Rescigno M: Probiotic and postbiotic
activity in health and disease: Comparison on a novel polarised
ex-vivo organ culture model. Gut. 61:1007–1015. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang M, Qiu X, Zhang H, Yang X, Hong N,
Yang Y, Chen H and Yu C: Faecalibacterium prausnitzii inhibits
interleukin-17 to ameliorate colorectal colitis in rats. PLoS One.
9:e1091462014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Atarashi K, Tanoue T, Oshima K, Suda W,
Nagano Y, Nishikawa H, Fukuda S, Saito T, Narushima S, Hase K, et
al: Treg induction by a rationally selected mixture of Clostridia
strains from the human microbiota. Nature. 500:232–236. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Duncan SH, Hold GL, Barcenilla A, Stewart
CS and Flint HJ: Roseburia intestinalis sp. nov., a novel
saccharolytic, butyrate-producing bacterium from human faeces. Int
J Syst Evol Microbiol. 52:1615–1620. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Calderón-Gómez E, Bassolas-Molina H,
Mora-Buch R, Dotti I, Planell N, Esteller M, Gallego M, Martí M,
Garcia-Martín C, Martínez-Torró C, et al: Commensal-specific CD4(+)
cells from patients with Crohn's disease have a T-Helper 17
inflammatory profile. Gastroenterology. 151:489–500.e3. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kryczek I, Wang L, Wu K, Li W, Zhao E, Cui
T, Wei S, Liu Y, Wang Y, Vatan L, et al: Inflammatory regulatory T
cells in the microenvironments of ulcerative colitis and colon
carcinoma. Oncoimmunology. 5:e11054302016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Laidlaw BJ, Cui W, Amezquita RA, Gray SM,
Guan T, Lu Y, Kobayashi Y, Flavell RA, Kleinstein SH, Craft J and
Kaech SM: Production of IL-10 by CD4(+) regulatory T cells during
the resolution of infection promotes the maturation of memory
CD8(+) T cells. Nat Immunol. 16:871–879. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kverka M, Zakostelska Z, Klimesova K,
Sokol D, Hudcovic T, Hrncir T, Rossmann P, Mrazek J, Kopecny J,
Verdu EF and Tlaskalova-Hogenova H: Oral administration of
Parabacteroides distasonis antigens attenuates experimental murine
colitis through modulation of immunity and microbiota composition.
Clin Exp Immunol. 163:250–259. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Arpaia N, Campbell C, Fan X, Dikiy S, van
der Veeken J, deRoos P, Liu H, Cross JR, Pfeffer K, Coffer PJ and
Rudensky AY: Metabolites produced by commensal bacteria promote
peripheral regulatory T-cell generation. Nature. 504:451–455. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ding Y, Xu J and Bromberg JS: Regulatory T
cell migration during an immune response. Trends Immunol.
33:174–180. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li J, Sung CY, Lee N, Ni Y, Pihlajamäki J,
Panagiotou G and El-Nezami H: Probiotics modulated gut microbiota
suppresses hepatocellular carcinoma growth in mice. Proc NatlAcad
Sci USA. 113:E1306–E1315. 2016. View Article : Google Scholar
|
